NDC 55292-911

Mustargen

Mechlorethamine Hydrochloride

Mustargen is a Intracavitary; Intravenous Powder, For Solution in the Human Prescription Drug category. It is labeled and distributed by Recordati Rare Diseases, . The primary component is Mechlorethamine.

Product ID55292-911_7b929598-948e-05d1-e053-2991aa0a9e4f
NDC55292-911
Product TypeHuman Prescription Drug
Proprietary NameMustargen
Generic NameMechlorethamine Hydrochloride
Dosage FormPowder, For Solution
Route of AdministrationINTRACAVITARY; INTRAVENOUS
Marketing Start Date1949-03-15
Marketing End Date2019-03-31
Marketing CategoryNDA /
Application NumberNDA006695
Labeler NameRECORDATI RARE DISEASES,
Substance NameMECHLORETHAMINE
Active Ingredient Strength10 mg/10mL
Pharm ClassesAlkylating Acti
NDC Exclude FlagN

Packaging

NDC SPL Data Element Entries

NDC 55292-911-51 [55292091151]

Mustargen POWDER, FOR SOLUTION
Marketing CategoryNDA
Application NumberNDA006695
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date1949-03-15
Marketing End Date2019-03-31

Drug Details

NDC Crossover Matching brand name "Mustargen" or generic name "Mechlorethamine Hydrochloride"

NDCBrand NameGeneric Name
55292-911Mustargenmechlorethamine hydrochloride
66215-016VALCHLORmechlorethamine hydrochloride
69639-120VALCHLORmechlorethamine hydrochloride

Trademark Results [Mustargen]

Mark Image

Registration | Serial
Company
Trademark
Application Date
MUSTARGEN
MUSTARGEN
71609343 0566271 Live/Registered
MERCK & CO., INC.
1951-01-27

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.